Brief: Mesoblast Posts Qtrly Loss After Tax $18.6 Mln
25/05/2023 23:30
May 26 (Reuters) - Mesoblast Ltd MSB.AX :
* QTRLY TOTAL REVENUE $1.9 MILLION VERSUS $2.0 MILLION
* QTRLY LOSS AFTER TAX $18.6 MILLION VERSUS LOSS $21.3
MILLION
Source text for Eikon: ID:nASX3njPrX
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast Reports QTRLY Ryoncil Net Revenues Of $30.3 Million
ASX-shares of Mesoblast rise after back-treatment drug hits patent target
Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech
Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
Brief: Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M